Skip to content

Addiction: all studies

Page 45 of 859: studies 441 to 450 of 8,590, newest first. Back to the addiction overview

Research

Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders

European Journal of Psychotraumatology 2021 Lukas A Basedow, Sören Kuitunen-Paul, Melina Wiedmann et al. 15 citations

ABSTRACT Background: Adolescent patients with a substance use disorder (SUD) often fulfil the criteria for a co-occurring post-traumatic stress disorder (PTSD). However, it is not clear if these dual-diagnosed adolescents present with unique levels of substance use and how their substance use relates to PTSD symptom clusters. Objective: To investigate substance use in adolescents with...

The Declaration of Interdependence! Feminism, Grounding and Enactivism.

Human Studies 2021 Anya Daly 7 citations

This paper explores the issue whether feminism needs a metaphysical grounding, and if so, what form that might take to effectively take account of and support the socio-political demands of feminism; addressing these demands I further propose will also contribute to the resolution of other social concerns. Social constructionism is regularly invoked by feminists and other political activists...

Traditional Use of Banisteriopsis caapi Alone and Its Application in a Context of Drug Addiction Therapy.

Journal of Psychoactive Drugs 2021 Matteo Politi, Fabio Friso, Gary Saucedo et al. 18 citations

Takiwasi is a therapeutic community for the treatment of Substance Use Disorders (SUDs) that combines traditional Amazonian medicine (TAM) with modern psychotherapy. One of the plant medicines from TAM used in this protocol is purgahuasca. It is a decoction of the vine Banisteriopsis caapi alone, whose use is traditional among the Awajún and other ethnic groups in Peru. The research began with...

Using Drugs to Treat Drug Dependence: Exploring the Use of MDMA-Assisted Psychotherapy for Individuals with PTSD and Concurrent Substance Use

Psychology and Behavioral Sciences 2021 Brenda Tichler

The importance of treating concurrent Post-Traumatic Stress Disorder (PTSD) and substance use with psychedelics is a controversial topic, hampered in part by a lack of empirical evidence and rigidity of substance scheduling. Traditional treatments for concurrent PTSD and substance use concerns are compartmentalized, with clinicians focusing on one condition over the other. In addition,...

5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.

Progress in Brain Research 2021 Guy A. Higgins, Edward M. Sellers 10 citations

Nicotine use and dependence, typically achieved through cigarette smoking, but increasingly through vape products, is the leading cause of preventable death today. Despite a recognition that many current smokers would like to quit, the success rate at doing so is low and indicative of the persistent nature of nicotine dependence and the high urge to relapse. There are currently three main forms...

Engineering Safer Psychedelics for Treating Addiction.

Neuroscience Insights 2021 Jamie Peters, David E. Olson 38 citations

Addiction is best described as a disorder of maladaptive neuroplasticity involving the simultaneous strengthening of reward circuitry that drives compulsive drug seeking and weakening of circuits involved in executive control over harmful behaviors. Psychedelics have shown great promise for treating addiction, with many people attributing their therapeutic effects to insights gained while under...

"This Is Something That Changed My Life": A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders.

Frontiers in Psychiatry 2021 Özden Merve Mollaahmetoğlu, Johanna Keeler, Katherine J Ashbullby et al. 62 citations

Background: The therapeutic benefits of ketamine have been demonstrated for a variety of psychiatric disorders. However, the role of ketamine induced psychoactive experiences in mediating the therapeutic effects is unclear. Despite the growing quantitative research on the efficacy of ketamine treatment, very few studies examined participant experiences of ketamine infusions in a treatment...

Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy

2021 Felix Betzler, Gerhard Gründer, Matthew W. Johnson et al.

Purpose of Review: The use of psychedelics in a therapeutical setting has been reported for the treatment of various diagnoses in recent years. However, as psychedelic substances are still commonly known for their ( illicit) recreational use, it may seem counterintuitive to use psychedelic therapy to treat substance use disorders. This review aims to discuss how psychedelics can promote and...

Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice.

European Neuropsychopharmacology December 2020 Yukihiro Noda, Mizuki Uchida, Akihiro Mouri et al.

The smoking incentive in patients with schizophrenia (SCZ) depends on stimulation of nicotinic acetylcholine receptors (nAChRs) in the central nervous system. To detect potential predictor genes for nicotine responses in SCZ, we explored common factor using research data in human and animal samples. In lymphoblastoid cell lines from SCZ, the mRNA expression level of α7 nAChR subunit was...